The pharmacological potential of mushrooms

Evidence-based Complementary and Alternative Medicine

Volumn 2, Issue 3, 2005, Pages 285-299

  Lindequist, Ulrike ^a   Niedermeyer, Timo H J ^a   Jülich, Wolf Dieter ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Antiatherogenic; Antimicrobial; Antitumor; Basidiomycetes; Bioactive compounds

Indexed keywords

5 ALPHA ERGOSTA 7,22 DIEN 3 BETA OL; 5,8 EPIDIOXY 5 ALPHA,8 ALPHA ERGOSTA 6,22 DIEN 3 BETA OL; ANTIALLERGIC AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; APPLANOXIDIC ACID A; EPICORAZIN DERIVATIVE; ERGOSTEROL PEROXIDE; FLAMMULIN; GANODERIC ACID DERIVATIVE; GANODERIOL F; GANODERMADIOL; GANODERMANONTRIOL; GANOMYCIN DERIVATIVE; GRIFOLA FRONDOSA EXTRACT; IMMUNOMODULATING AGENT; INONOTUS HISPIDUS EXTRACT; KUEHNEROMYCES MUTABILIS EXTRACT; LENTINAN; LENTINULA EDODES EXTRACT; LIGNIN; LIGNIN DERIVATIVE; LIVER PROTECTIVE AGENT; LUCIDADIOL; OXALIC ACID; PURINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VELUTIN;

AGARICUS BISPORUS; AGARICUS BLAZEI; AGARICUS BRASILIENSIS; ALLERGY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; CALVATIA CAELATA; CANCER SURVIVAL; CLINICAL TRIAL; COLLYBIA MACULATA; COLORECTAL CANCER; CORIOLUS VERSICOLOR; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; FLAMMULINA VELUTIPES; GANODERMA ANNULARE; GANODERMA APPLANATUM; GANODERMA LUCIDUM; GANODERMA PFEIFFERRI; GANOPOLY LUCIDUM; GRIFOLA FRONDOSA; HANDKEA UTRIFORMIS; HERICIUM CAPUT MEDUSAE; HERICIUM ERINACEUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPSIZYGUS MARMOREUS; IMMUNOMODULATION; INONOTUS HISPIDUS; INONOTUS OBLIQUUS; INSOMNIA; KUEHNEROMYCES MUTABILIS; LACTARIUS VELLEREUS; LENTINUS EDODES; LIVER PROTECTION; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUSHROOM; NAUSEA; NONHUMAN; PARAMECICUM CAUDATUM; PHELLINUS RIMOSUS; PIPTOPORUS BETULINUS; PLEUROTUS OSTREATUS; PRIORITY JOURNAL; RASH; REVIEW; SPARASSIS CRISPA; SUNBURN; TRAMETES LOBAYENSE; TRAMETES MESENTERICA; TRAMETES VERSICOLOR; TRICHOLOMA MONGOLICUM;

EID: 24344469750     PISSN: 1741427X     EISSN: None     Source Type: Journal    
DOI: 10.1093/ecam/neh107     Document Type: Review

References (157)

1. Hobbs C. Medicinal Mushrooms. Santa Cruz: Botanica Press, 1995.
2. Lelley J. Die Heilkraft der Pilze. Berlin: ECON-Verlag, 1997.
3. Lindequist U. Ganoderma. In: Schneider G, Hänsel R, Blaschek W (eds). HAGERs Handbuch der Pharmazeutischen Praxis. Berlin, Heidelberg, New York: Springer-Verlag, 1998, 750-61 (in German).
4. Lindequist U. Lentinula. In: Schneider G, Hänsel R, Blaschek W (eds). HAGERs Handbuch der Pharmazeutischen Praxis. Berlin, Heidelberg, New York: Springer-Verlag, 1998, 61-71 (in German).
5. Lindequist U. Schizophyllum. In: Schneider G, Hänsel R, Blaschek W (eds). HAGERs Handbuch der Pharmazeutischen Praxis. Berlin, Heidelberg, New York: Springer-Verlag, 1998, 528-34 (in German).
6. Stamets P. Growing Gourmet and Medicinal Mushrooms. Berkely: Ten Speed Press, 2000.
7. Zjawiony J. Biologically active compounds from Aphyllophorales (Polypore) fungi. J Nat Prod 2004;67:300-10.
8. Chang ST. Mushroom research and development - equality and mutual benefit. In: Royse DJ (ed). Proceedings of the 2nd International Conference on Mushroom Biology and Mushroom Products. Pennsylvania State University, 1996, 1-10.
9. Wasser SP, Nevo E, Sokolov D, Reshetnikov S, Timot-Tismenetsky M. Dietary supplements from medicinal mushrooms: diversity of types and variety of regulations. Int J Med Mushrooms 2000;2:1-19.
10. Chang ST, Miles PG. Mushrooms biology - a new discipline. Mycologist 1992;6:64-5.
11. Hawksworth DL. Mushrooms: the extent of the unexplored potential. Int J Med Mushrooms 2001;3:333-7.
12. Lindequist U, Teuscher E, Narbe G. Neue Wirkstoffe aus Basidiomyceten. Z Phytother 1990;11:139-49 (in German).
13. Mothana RAA, Jansen R, Jülich W-D, Lindequist U. Ganomycin A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod 2000;63:416-8.
14. Smania EFA, Delle Monache F, Smania Jr A, Yunes RA. Cuneo. Antifungal activity of sterols and triterpenes isolated from Ganoderma annulare. Fitoterapia 2003;74:375-7.
15. Smania Jr A, Delle Monache F, Smania EFA, Cuneo RS. Antibacterial activity of steroidal compounds isolated from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) fruit body. Int J Med Mushrooms 1999;1:325-30.
16. Bender S, Dumitrache CN, Backhaus J, Christie G, Cross RF, Lonergan GT, et al. A case for caution in assessing the antibiotic activity of extracts of culinary-medicinal Shiitake mushroom [Lentinus edodes (Berk.)Singer] (Agaricomycetidae). Int J Med Mushrooms 2003;5:31-5.
17. Badalyan SM. Antiprotozoal activity and mitogenic effect of mycelium of culinary-medicinal shiitake mushroom Lentinus edodes (Berk.) Singer (Agaricomycetidae). Int J Med Mushrooms 2004;6:131-8.
18. Al-Fatimi MAM. Isolierung und Charakterisierung antibiotisch wirksamer Verbindungen aus Ganoderma pfeifferi Bres. und aus Podaxis pistilhiris (L.:Pers.) Morse. Universität Greifswald, 2001 (in German).
19. Brandt CR, Piraino F. Mushroom antivirals. Recent Res Dev Antimicrob Agents Chemother 2000;4:11-26.
20. El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 1998;49:1651-7.
21. Mothana RAA, Awadh NAA, Jansen R, Wegner U, Mentel R, Lindequist U. Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi BRES. Fitoterapia 2003;74:177-80.
22. Mentel R, Meinsen D, Pilgrim H, Herrmann B, Lindequist U. In vitro antiviral effect of extracts of Kuehneromyces mutabilis on influenza virus. Pharmazie 1994;49:859-60.
23. Awadh AAN, Mothana RAA, Lesnau A, Pilgrim H, Lindequist U. Antiviral activity of extracts and compounds from Inonotus hispidus. Fitotherapia 2003;74:483-5.
24. Lindequist U, Lesnau A, Teuscher E, Pilgrim H. Untersuchungen zur antiviralen Wirksamkeit von Ergosterolperoxid. Pharmazie 1989;44:579-80 (in German).
25. Leonhardt K, Anke T, Hillen-Maske E, Steglich W. 6-Methylpurine, 6-methyl-9-β-D-ribofuranosyl-purine, and 6-hydroxymethyl-9-β-D- ribofuranosyl-purin as antiviral metabolites of Collybia maculata (basidiomycetes). Z Naturforsch C 1987;42:420-4.
26. Ichimura T, Watanabe O, Maruyama S. Inhibition of HIV-1 protease by water-soluble lignin-like substance from an edible mushroom, Fuscoporia obliqua. Biosci Biotechnol Biochem 1998;62:575-7.
27. Tochikura TS, Nakashima H, Ohashi Y, Yamamoto N. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med Microbiol Immunol 1988;177:235-44.
28. Suzuki H, Okubo A, Yamazaki S, Suzuki K, Mitsuya H, Toda S. Inhibition of the infectivity and cytopathic effect of human immunodeficiency virus by water-soluble lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM). Biochem Biophys Res Commun 1989;160:367-73.
29. Yoshida O, Nakashima H, Yoshida T, Kaneko Y, Yamamoto I, Matsuzaki K, et al. Sulfation of the immunomodulating polysaccharide lentinan: a novel strategy for antivirals to human immunodeficiency virus (HIV). Biochem Pharmacol 1988;37:2887-91.
30. Tochikura TS, Nakashima H, Hirose K, Yamamoto N. A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro. Biochem Biophys Res Commun 1987;148:726-33.
31. Colins RA, Ng TB. Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection. Life Sci 1997;60:PL383-7.
32. Wang HX, Ng TB. Isolation and characterization of velutin, a novel low-molecular-weight ribosome-inactivating protein from winter mushroom (Flammulina velutipes) fruiting bodies. Life Sci 2001;68:2151-8.
33. Nanba H, Kodama N, Schar D, Turner D. Effects of maitake (Grifola frondosa) glucan in HIV-infected patients. Mycoscience 2000;41:293-5.
34. Semerdzieva M, Veselsky J. Lecive houby drive a nyni. Academia Praha, 1986 (in Czech).
35. Molitoris HP. Mushrooms in medicine. Folia Microbiol 1994;39:91-8.
36. Kahlos K, Kangas L, Hiltunen R. Antitumor activity of some compounds and fractions from an n-hexane extract of Inonotus obliquus in vitro. Acta Pharm Fennica 1987;96:33-40.
37. Burczyk J, Gawron A, Slotwinska M, Smietana B, Terminska K. Antimitotic activity of aqueous extracts of Inonotus obliquus. Boll Chim Farm 1996;135:306-9.
38. Babitskaya VG, Scherba VV, Ikonnikova NV, Bisko NA, Mitropolskaya NY. Melanin complex from medicinal mushroom Inonotus obliquus (Pers.:Fr.) Pilat (Chaga) (Aphyllophoromycetidae). Int J Med Mushrooms 2002;4:139-45.
39. Chihara G, Maeda Y, Sasaki T, Fukuoka F. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.). Nature 1969;222:687-8.
40. Mizuno T. The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan (review). Int J Med Mushrooms 1999;1:9-30.
41. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int J Med Mushrooms 1999;1:31-62.
42. Reshetnikov SV, Wasser SP, Tan KK. Higher basidiomycetes as a source of antitumor and immunostimulating polysaccharides (review). Int J Med Mushrooms 2001;3:361-94.
43. Zhou S, Gao Y. The immunomodulating effects of Ganoderma lucidum (Curt.:Fr.) P.Karst (LingZhi, Reishi Mushroom) (Aphylloromycetidae). Int J Med Mushrooms 2002;4:1-11.
44. Karinaga R, Mizu M, Koumoto K, Anada T, Shinkai S, Kimura T, et al. First observation by fluorescence polarization of complexation between mRNA and the natural polysaccharide schizophyllan. Chem Biodivers 2004;1:634-9.
45. Adachi Y, Suzuki Y, Jinushi T, Yadomae T, Ohno N. Th1-oriented immunomodulating activity of gel-forming fungal (1-3)-beta-glucans. Int J Med Mushrooms 2002;4:95-109.
46. Nanba H, Hamaguchi A, Kuroda H. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem Pharm Bull (Tokyo) 1987;35:1162-8.
47. Kodama N, Komuta K, Nanba H. Effect of maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients. J Med Food 2003;6:371-7.
48. Hazama S, Oka M, Yoshino S, Iizuka N, Wadamori K. Yamamoto, et al. Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma. Cancer Chemother 1995;22:1595-7.
49. Ochiai T, Isono K, Suzuki T, Koide Y, Gunji Y, Nagata M, et al. Int J Immunother 1992;8:161-9.
50. Taguchi T, Furue H, Kimura T, Kondoh T, Hattori T, Itoh I, et al. Life-span prolongation effect of lentinan on patients with advanced or recurrent colorectal cancer. Int J Immunopharmacol 1982;4:271.
51. Fujimoto S, Furue H, Kimura T, Kondo T, Orita K, Taguchi T, et al. Clinical outcome of postoperative adjuvant immunochemotherapy with sizofiran for patients with resectable gastric cancer - a randomised controlled study. Eur J Cancer 1991;27:1114-8.
52. Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Dis Colon Rectum 1992;35:123-30.
53. Yang QY. A new biological response modifier - PSP. In: Chang ST (ed). Mushroom Biology and Mushroom Products. Hong Kong: The Chinese University Press, 1993, 247-59.
54. Gordon M, Guralnik M, Kaneko Y, Mimura T, Goodgame J, DeMarzo C, et al. A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (DDI) in HIV patients with CD4 cells of 200-500/MM(3). J Med 1995;26:193-207.
55. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev 2002;7:236-9.
56. Konno S, Aynehchi S, Dolin DJ, Schwartz AM, Choudhury MS, Tazakin HN. Anticancer and hypoglycemic effects of polysaccharides in edible and medicinal Maitake mushroom [Grifola frondosa (Dicks.:Fr.) S.F.Gray]. Int J Med Mushrooms 2002;4:185-95.
57. Yap AT, Ng ML. Immunopotentiating properties of lentinan (1-3)- β-D-glucan extracted from culinary-medicinal Shiitake mushroom Lentinus edodes (Berk.) Singer (Agaricomycetidae). Int J Med Mushrooms 2003;5:339-58.
58. Bodinet C, Lindequist U, Teuscher E, Freudenstein J. Influence of peroral application of a herbal immunomodulator on the antibody production of Peyer's Patches-cells. Arzneim Forsch 2004;54:114-8.
59. Gao Y, Dai X, Chen G, Ye J, Zhou S. A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphylloromycetidae) polysaccharides (Ganopoly R) in patients with advanced lung cancer. Int J Med Mushrooms 2003;5:369-81.
60. Gao Y, Zhou S, Chen G, Dai X, Ye J. A phase I/II study of a Ganoderma lucidum (Curt.:Fr.) P.Karst. extract (Ganopoly) in patients with advanced cancer. Int J Med Mushrooms 2002;4:207-14.
61. Ohno N, Harada T, Masuzawa S, Miura NN, Adachi Y, Nakajima M, et al. Antitumor activity and hematopoietic response of a β-glucan extracted from an edible and medicinal mushroom Sparassis crispa Wulf.:Fr. (Aphylloromycetidae) . Int J Med Mushrooms 2002;4:13-26.
62. Ohno N, Nameda S, Harada T, Miura NN, Adachi Y, Nakajima M, et al. Immunomodulating activity of a β-glucan preparation, SCG, extracted from a culinary-medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetidae), and application to cancer patients. Int J Med Mushrooms 2003;5:359-68.
63. Mizuno T. Bioactive substances in Hericium erinaceus (Bull.:Fr.) Pers. (Yamabushitake), and its medicinal utilization. Int J Med Mushrooms 1999;1:105-19.
64. Stijve T, de A Amazonas MA, Giller V. Flavour and taste components of Agarius blazei Murrill ss. Heinem. - a new gourmet and medicinal mushroom. Dtsch Lebensm-Rundsch 2002;98:448-53.
65. Wasser SP, Didukh MY, de A Amazonas MAL, Nevo E, Stamets P, da Eira AF. Is a widely cultivated culinary-medicinal royal sun Agaricus (the Himematsutake mushroom) indeed Agaricus blazer Murrill? Int J Med Mushrooms 2002;4:267-90.
66. Mizuno T. Medicinal properties and clinical effects of culinary-medicinal mushroom Agaricus blazei Murrill (Agaricomycetidae) (Review). Int J Med Mushrooms 2002;4:299-312.
67. Yuexin L, Zhuqiu Y, Yanyan H, Hualing X. Fractionation and characterization of water-soluble polysaccharides from culinary-medicinal mushroom, Agaricus blazei Murrill (Agaricomycetidae) fruit body. Int J Med Mushrooms 2002;4:313-9.
68. Menoli RC, Mantovani MS, Ribeiro LR, Speit G, Jordalo BQ. Antimutagenic effects of the mushroom Agaricus blazei Murrill extracts on v79 cells. Mutat Res 2001;12:5-13.
69. Lam YW, Ng TB, Wang HX. Antiproliferative and antimitogenic activities in a peptide from puffball mushroom Calvatia caelata. Biochem Biophys Res Commun 2001;289:744-9.
70. Lam SK, Ng TB. Hypsin, a novel thermostable ribosome inactivating protein with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. Biochem Biophys Res Commun 2001;285:1071-5.
71. Yu LG, Fernig DJ, Smith JA, Milton JD, Rhodes JM. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res 1993;53:4627-32.
72. Wang HX, Gao J, Ng TB. A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem Biophys Res Commun 2000;275:810-6.
73. Zusman I, Reifen R, Livni O, Smirnoff P, Gurevich P, Sandler B, et al. Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus. Anticancer Res 1997;17:2105-13.
74. Gerasimenya VP, Efremenkova OV, Kamzolina OV, Bogush TA, Tolstych IV, Zennkova VA. Antimicrobial and antitoxical action of edible and medicinal mushroom Pleurotus ostreatus (Jacq,:Fr.) Kumm. Extracts. Int J Med Mushrooms 2002;4:127-32.
75. Ajith TA, Janardhanan KK. Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat. J Ethnopharmacol 2003;84:157-62.
76. McMorris TC, Keiner MJ, Wang W, Estas LA, Montoya MA, Taetle R. Structure-activity relationships of illudin analogs with improved therapeutic index. J Org Chem 1992;57:6876-83.
77. Hartting U, Anke T, Scherer A, Steglich W. Leaianafulvene, a sesquiterpenoid fulvene derivative from culture of Mycena leaviana. Phytochemistry 1990;29:3942-4.
78. Toth JO, Luu B, Ourisson G. Ganoderic acid T and Z: cytotoxic triterpenes from Ganoderma lucidum (Polyporaceae). Tetrahedron Lett 1983;24:1081-4.
79. Toth JO, Luu B, Beck JP, Ourisson G. Chemistry and biochemistry of Oriental drugs. Part IX. Cytotoxic triterpenes from Ganoderma lucidum (Polyporaceae): structures of ganoderic acids U-Z. J Chem Res Synop 1983;12:299.
80. Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull 2002;50:837-40.
81. Leon F, Valencia M, Augusto R, Nieto I, Quintana J, Estevez F, et al. Novel cytostatic lanostanoid triterpenes from Ganoderma australe. Helv Chim Acta 2003;86:3088-95.
82. Nam KS, Jo YS, Kim YH, Hyun JW, Kim HW. Cytotoxic activities of acetoxyscirpenediol and ergosterol peroxide from Paecilomyces tenuipes. Life Sci 2001;69:229-37.
83. Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GHN. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999;51:891-8.
84. Han HC, Lindequist U, Hyun JW, Kim YH, An HS, Lee DH, et al. Apoptosis induction by acetoxyscirpendiol from Paecilomyces tenuipes in human leukaemia cell lines. Pharmazie 2004;59:42-9.
85. Gonzalez AG, Leon F, Rivera A, Padron JI, Gonzalez-Plata J, Zuluaga JC, et al. New lanostanoids from the fungus Ganoderma concinna. J Nat Prod 2002;65:417-21.
86. Chairul, Tokuyama T, Hayashi Y, Nishizawa M, Tokuda H, Chairul SM, et al. Applanoxidic acids A, B, C and D, biologically active tetracyclic triterpenes from Ganoderma applanatum. Phytochemistry 1991;30:4105-9.
87. Chairul, Chairul SM, Hayashi Y. Lanostanoid triterpenes from Ganoderma applanatum. Photochemistry 1994;35:1305-8.
88. Murgo A, Cannon DJ, Blatner G, Cheson BD. Clinical trials of MGI-114. Oncology 1999;13:233-8.
89. Lee S, Park S, Oh JW, Yang C. Natural inhibitors for protein prenyltransferase. Planta Med 1998;64:303-8.
90. Kim SH, Song YS, Kim SK, Kim BC, Lim CJ, Park EH. Anti-inflammatory and related pharmacological activities of the n-BuOH subfraction of mushroom Phellinus linteus. J Ethnopharmacol 2004;93:141-6.
91. Cho JH, Cho SD, Hu H, Kim SH, Lee SK, Lee YS, et al. The roles of ERK 1/2 and p38 MAP kinases in the prevention mechanism of mushroom Phellinus linteus against the inhibition of gap junctional intercellular communication by hydrogen peroxide. Carcinogenesis 2002;23:1164-9.
92. Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murrill and mechanism of action. J Nutr 2001;5:1409-13.
93. Hashimoto T, Asakawa Y. Biologically active substances of Japanese inedible mushrooms. Heterocycles 1998;47:1067-110.
94. Lakshmi B, Jose N, Ajith TA, Jananrdhanan KK. Antimutagenic activity of methanolic extract of culinary-medicinal oyster mushroom, Pleurotus ostreatus (Jacq.:Fr.) Kumm. (strain floric Eger nom. Nud.) and its protective effect against benzo[a]pyrene-induced hepatic damages. Int J Med Mushrooms 2004;6:139-49.
95. Mlinrič A, Kac J, Fatur T, Filini M. Anti-genotoxic activity of the mushroom Lactarius vellereus extract in bacteria and in mammalian cells in vitro. Pharmazie 2004;59:217-21.
96. Shi YL, James AE, Benzie IFF, Buswell JA. Genoprotective activity of edible and medicinal mushroom components. Int J Med Mushrooms 2004;6:1-14.
97. Bobek P, Galbavỳ Š, Ozdǐn L. Effect of oyster mushroom (Pleurotus ostreatus) on pathological changes in dimethylhydrazine- induced rat colon cancer. Oncol Rep 1998;5:727-30.
98. Sano M, Yoshino K, Matsuzawa T, Ikekawa T. Inhibitory effects of edible higher basidiomycetes mushroom extracts on mouse type IV allergy. Int J Med Mushrooms 2002;4:37-41.
99. Kohda H, Tokumoto W, Sakamoto K, Fujii M, Hirai Y, Yamasaki K, et al. The biologically-active constituents of Ganoderma lucidum (Fr) Karst - histamine release-inhibitory triterpenes. Chem Pharm Bull 1985;33:1367-73.
100. Tasaka K, Mio M, Izushi K, Akagi M, Makino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions 1988;23:157-60.
101. Lindequist U, Teuscher E, Wolf B, Völsgen A, Hoffmann S, Kutschabsky L, et al. Isolierung, Charakterisierung und Strukturaufklärung eines immunsuppressiv wirksamen Inhaltsstoffes aus Tricholoma populinum LANGE. Pharmazie 1989:44:165 (in German).
102. Kreisel H, Lindequist U, Horak M. Distribution, ecology and immunosuppressive properties of Tricholoma populinum (Basidiomycetes). Zentralbl Mikrobiol 1990;145:393-6.
103. Ali NAA, Pilgrim H, Lüdke J, Lindequist U. Inhibition of chemiluminescence response of human mononuclear cells and suppression of mitogen-induced proliferation of spleen lymphocytes of mice by hispolon and hispidin. Pharmazie 1996;51:667-70.
104. Koch J, Witt S, Lindequist U. The influence of selected basidiomycetes on the binding of lipopolysaccharide to its receptor. Int J Med Mushrooms 2002;4:229-35.
105. Min BS, Gao JJ, Hattori M, Lee HK, Kim YH. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med 2001;67:811-4.
106. Bobek P, Galbavỳ Š. Hypocholesteremic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung 1999;43:339-42.
107. Gunde-Cimerman N, Friedrich J, Cimerman A, Benički N. Screening fungi for the production of an inhibitor of HMG-CoA reductase - production of mevinolin by the fungi of the genus Pleurotus. FEMS Microbiol Lett 1993;111:203-6.
108. Chen Q. Antilipemic effect of polysaccharides from Auricularia auricular, Tremella fuciformis, and Tremella fuciformis spores. Zhongguo Yaoke Daxue Xuebao 1989;20:344-7.
109. Cheung PCK. The hypocholesterolemic effect of two edible mushrooms: Auricularia auricula (tree-ear) and Tremella fuciformis (white jelly-leaf) in hypercholesterolemic rats. Nutr Res 1996;16:1721-5.
110. Komoda Y, Shimizu M, Sonoda Y, Sato Y. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull 1989;37:531-3.
111. Morigiwa A, Kitabatake K, Fujimoto Y, Ihekawa N. Angiotensin converting enzyme inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull 1986;34:3025-8.
112. Su CY, Shiao MS, Wang CT. Predominant inhibition of ganodermic acid S on the thromboxane A2-dependent pathway in human platelets response to collagen. Biochim Biophys Acta 1999;1437:223-34.
113. Lin ZB. Focus on anti-oxidative and free radical scavening activity of Ganoderma lucidum. J Appl Pharmacol 2004;12:133-7.
114. Tokuda S, Tapiri A, Kano E, Sugwara Y, Suzuki S, Sato H, et al. Reducing mechanism of plasma cholesterol by Shii-ta-ke. Mushroom Sci 1974;9:445-61.
115. Liu JK, Hu L, Dong ZJ, H Q. DPPH radical scavenging activity of ten natural p-terphenyl derivatives obtained from three edible mushrooms indigenous to China. Chem Biodivers 2004;1:601-5.
116. Yun BS, Lee Iky, Kim JP, Yoo ID. Two p-terphenyls from mushroom Paxillus panuoides with free radical scavenging activity. J Microbiol Biotechnol 2000;10:233-7.
117. Lee IK, Yun BS, Cho SM, Kim WG, Kim JP, Ryoo IJ, et al. Betulinans A and B, two Benzoquinone Compounds from Lenzites betulina. J Nat Prod 1996;59:1090-2.
118. Yun BS, Cho Y, Lee IK, Cho SM, Lee TH, Yoo ID. Sterins A and B, new antioxidative compounds from Stereum hirsutum. J Antibiot 2002;55:208-10.
119. Yuan D, Mori J, Komatsu K, Makino T, Kano Y. An anti-aldosteronic diuretic component (drain dampness) in Polyporus sclerotium. Biol Pharm Bull 2004;27:867-70.
120. Lu W, Adachi I, Kano K, Yasuta A, Toriizuka K, Ueno M, et al. Platelet aggregation potentiators from Cho-Re. Chem Pharm Bull 1985;33:5083-7.
121. Hikino H, Konno C, Mirin Y, Hayashi T. Isolation and hypoglycaemic activities of ganoderans A and B, glucans of Ganoderma lucidum fruit bodies. Planta Med 1985;51:339-40.
122. Ikuzawa M, Oguchi Y, Matsunaga K, Toyoda N, Furusho T, Fujii T, et al. Pharmaceutical preparation containing a glycoprotein. German Patent DE 3,429,551, 1985.
123. Kiho T, Morimoto H, Kobayashi T, Ysai S, Ukai S, Aizawa K, et al. Effect of a polysaccharide (TAP) from the fruiting bodies of Tremella aurantia on glucose metabolism in mouse liver. Biosci Biotechnol Biochem 2000;64:417-9.
124. Gao Y, Lan J, Dai X, Ye J, Zhou S. A phase I/II study of ling zhi mushroom Ganoderma lucidum (W.Curt.:Fr.)Lloyd (Aphyllophoromycetidae) extract in patients with type II diabetes mellitus. Int J Med Mushrooms 2004;6:33-9.
125. Wasser SP, Tan KK, Elisashvili VI. Hypoglycemic, interferonogenous, and immunomodulatory activity of Tremellastin from the submerged culture of Tremella mesenterica Retz.:Fr. (Heterobasidiomycetes). Int J Med Mushrooms 2002;4:215-27.
126. Hsu TH, Lo HC. Biological activity of Cordyceps (Fr.) Link species (ascomycetes) derived from a natural source and from fermented mycelia on diabetes in STZ-induced rats. Int J Med Mushrooms 2002;4:111-25.
127. Kiho T, Ookubo K, Usui S, Ukai S, Hirano K. Structural features and hypoglycaemic activity of a polysaccharide (CS-F10) from the cultured mycelium of Cordyceps sinensis. Biol Pharm Bull 1999;22:966-70.
128. Mizuno T. Medicinal effects and utilization of Cordyceps (Fr.) Link (Ascomycetes) and Isaria Fr. (mitosporic fungi) Chinese caterpillar fungi, "Tochukaso" (review). Int J Med Mushrooms 1999;1:251-61.
129. Sato M, Tai T, Nunoura Y, Yajima Y, Kawashima S, Tanaka K. Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharm Bull 2002;25:81-6.
130. Kim GY, Kim SH, Hwang SY, Kim HY, Park YM, Park SK, et al. Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice. Biol Pharm Bull 2003;26:823-31.
131. Koyama K, Imaizumi T, Akiba M, Kinoshita K, Takahashi L, Suzuki A, et al. Antinociceptive components of Ganoderma lucidum. Planta Med 1997;63:224-7.
132. Jose N, Ajith TA, Jananrdhanan KK. Antioxidant, anti-inflammatory, and antitumor activities of culinary-medicinal mushroom Pleurotus pulmonarius (Fr.) Quél. (Agaricomycetidae). Int J Med Mushrooms 2002;4:329-35.
133. Zhang Y, Mills G, Nair MG. Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa. J Agric Food Chem 2002;50:7581-5.
134. Hirotani M, Ino C, Furuya T, Shiro M. Ganoderic acids T, S and R, new triterpenoids from the cultured mycelia of Ganoderma lucidum. Chem Pharm Bull 1986;34:2282-5.
135. Chen RY, Yu DQ. Studies on the triterpenoid constituents of the spores from Ganoderma lucidum Karst. J Chin Pharm Sci 1993:2:91-6.
136. Wang MY, Liu Q, Che QM, Lin ZB. Effects of total triterpenoids extract from Ganoderma lucidum (Curt.:Fr.) P.Karst. (Reishi Mushroom) on experimental liver injury models induced by carbon tetrachloride or D-galactosamine in mice. Int J Med Mushrooms 2002;4:337-42.
137. Gao Y, Zhou S, Chen G, Dai X, Ye J, Gao H. A phase I/II study of a Ganoderma lucidum (Curt.:Fr.) P.Karst. (Ling Zhi, Reishi mushroom) extract in patients with chronic hepatitis B. Int J Med Mushrooms 2002;4:2321-7.
138. Saito T, Aoki F, Hirai H, Inagaki T, Matsunaga Y, Sakakibara T, et al. Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. J Antibiot 1998;51:983-90.
139. Melzig MF, Pieper S, Siems WE, Heder G, Böttger A, Liberra K, et al. Screening of selected basidiomycetes for inhibitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE). Pharmazie 1996;51:501-3.
140. Szallasi A, Biro T, Szabo T, Modarres S, Petersen M, Klusch A, et al. A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Br J Pharmacol 1999;126:1351-8.
141. Liu J. Biologically active substances from mushrooms in Yunnan, China. Heterocycles 2002;57:157-67.
142. Chang ST. A 40-year journey through bioconversion of lignocellulosic wastes to mushrooms and dietary supplements. Int J Med Mushrooms 2001;3:299-310.
143. Kim HW, Kim BK. Biomedicinal triterpenoids of Ganoderma lucidum (Curt.: Fr.) P.Karst (Aphyllophoromycetidae). Int J Med Mushrooms 1999;1:121-38.
144. Mizuno T, Inagaki R, Kanao T, Hagiwara T, Nakamura T, Ito H, et al. Antitumor activity and some properties of water-soluble polysaccharides from "Himematsutake", the fruiting body of Agaricus blazei Murill. Agric Biol Chem 1990;54:2889-96.
145. Mizuno M, Kawakami S, Sakamoto Y, Fujitake N. Macrophages stimulated by polysaccharide purified from Agaricus brasiliensis S. Wasser et al. (Agaricomycetidae) enhance mRNA expression of Th1 cytokine including IL-12 and 18. Int J Med Mushrooms 2003;5:383-9.
146. Kitamura S, Hori T, Kurita K, Takeo K, Hara C, Itoh W, et al. An antitumor, branched (1-3)-β-D-glucan from a water extract of fruiting bodies of Cryptoporus volvatus. Carbohydr Res 1994;263:111-21.
147. Watanabe Y, Nakanishi K, Komatsu N, Sakabe T, Terakawa H. Flammulin, an antitumor substance. Bull Chem Soc Jpn 1964;37:747-50.
148. Lee SS, Lee PL, Chen CF, Wang SY, Chen KY. Antitumor effects of polysaccharides of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) (Aphyllophoromycetidae). Int J Med Mushrooms 2003;5:1-16.
149. Ohno N, Adachi Y, Suzuki I, Sato K, Oikawa S, Yadomae T. Characterization of antitumor glucan obtained from liquid-cultured Grifola frondosa. Chem Pharm Bull 1986;34:1709-15.
150. Chihara G. Medical aspects of lentinan isolated from Lentinus edodes (Berk.) Sing. In: Chang ST, Buswell JA, Chiu SW (eds). Mushroom Biology and Mushroom Products. Hong Kong: The Chinese University Press, 1993, 261-6.
151. Lin Y, Lai P, Huang Y, Xie H. Immune-competent polysaccharides from the submerged cultured mycelium of culinary-medicinal mushroom Lentinus strigellus Berk. & Curt. (Agaricomycetidae). Int J Med Mushrooms 2004;6:49-55.
152. Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID, Yang KH, et al. The inhibitory effect of polysaccharides from Phellinus linteus on tumor growth and metastasis. Immunopharmacology 1999;41:157-64.
153. Ohno H, Miura NN, Nakajima M, Yadomae T. Antitumor 1,3-β-glucan from cultured fruit body of Sparassis crispa. Biol Pharmaceul Bull 2000;23:866-72.
154. Sakagami H, Takeda M. Diverse biological activity of PSK (Krestin), a protein-bound polysaccharide from Coriolus versicolor (Fr.) Quel. In: Chang ST (ed). Mushroom Biology and Mushroom Products. Hong Kong: The Chinese University Press, 1993, 237-45.
155. DeBaets S, Vandamme J. Extracellular Tremella polysaccharides: structures, properties and application. Biotechnol Lett 2001;23:1361-6.
156. Wang HX, Liu WK, Ng TB, Ooi VEC, Chang ST. Immunomodulatory and antitumor activities of polysaccharide-peptide complex from a mycelial culture of Tricholoma lobayense, a local edible mushroom. Life Sci 1995;57:269-81.
157. Wang HX, Liu WK, Ng TB, Ooi VEC, Chang ST. The immunomodulatory and antitumor activities of lectins from the mushroom Tricholoma mongolicum. Immunopharmacology 1996;31:205-11.